Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Advertising
 

EquipNet Auction: Sell Your Used Lab and Analytical Equipment Now!

North American Biotech Roadshow Featuring Grad Students, Post-Docs & Start-Up “Do’s & Don’ts”

Check Out Our Newest Cartoon: Your COVID-19 Wheel of Fortune


New York Life Science Industry Directory

EquipNet Auction: Sell your surplus on our global marketplace: No cost to list equipment!

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2022 replacing New YorkLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Roswell Park Cancer Institute, Technology Transfer


Roswell Park Cancer Institute, Technology Transfer
Elm & Carlton Sts.
Buffalo, NY 14263
Roswell Park Cancer Institute, Technology Transfer
 
Phone: (716) 845-4358
Fax: (716) 845-4358
Year Established:  1898
Main Contact: Aldona Cytraus, VP for Science & CCSG Admin.
 
Company Description

Roswell Park Cancer Institute (RPCI), founded in 1898, is the nation’s first cancer research, treatment and education center, and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI also is a member of the National Comprehensive Cancer Network. RPCI's 25-acre campus on the Buffalo Niagara Medical Campus includes approximately 1.5 million square feet of space. Approximately 60% of the campus has been renovated or newly built since 1998. The newest building on the RPCI campus, the 170,000 square feet Center for Genetics and Pharmacology, will open in Spring 2006.

RPCI’s mission is to conduct investigations regarding cancer etiology, prevention, mortality and treatment. . The Institute’s 21 clinical, scientific and prevention departments conduct interdisciplinary research through six major programs (Biophysical Therapies, Cancer Prevention, Genetics, Prostate, Targeted Therapeutics, and Tumor Immunology) based on five broad objectives that are fully integrated with Cancer Center Support Grant functions.

RPCI’s multidisciplinary centers include: Breast, Dermatology, Sarcoma, Melanoma, Thoracic, Gynecology, Head & Neck/Dental, Leukemia, Lymphoma, Multiple Myeloma, Neuro-Oncology & Pain Management, Pediatrics, Gastrointestinal and Urologic cancers. RPCI also offers specialized services and therapies not available elsewhere in the region, including: hematopoietic stem cell transplantation, photodynamic therapy; gamma knife radiosurgery; clinical genetics testing and counseling, a clinic for long-term survivors of childhood cancers, a regional center for maxillofacial prosthetics, the Buffalo-Niagara Prostate Cancer Consortium, a center for HIV-related malignancies, and a lymphedema clinic.

The RPCI Graduate Division of the University at Buffalo offers doctoral programs in the areas of Cancer Pathology and Prevention, Cellular and Molecular Biology, Immunology, Molecular and Cellular Biophysics and Biochemistry and Molecular Pharmacology and Cancer Therapeutics and an Interdisciplinary Master of Science Program. The Department of Educational Affairs coordinates the training of approximately 250 clinical residents, oncology fellows and visiting MDs each year, in addition to approximately 100 postdoctoral research fellows and 180 predoctoral graduate students.



Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

NewYorkLifeScience.com is owned and published by Info.Resource, Inc.